Friday, September 25, 2020

Granules India gets USFDA nod for sleep aid drug

Granules India gets USFDA nod for sleep aid drug The US Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) for Naproxen Sodium and Diphenhydramine Hydrochloride tablets, 220 mg/25 mg (OTC), Granules said in a BSE filing.

from Moneycontrol Business News https://ift.tt/367wwdq
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Nifty eyes relief rally on tariff hopes, FIIs remain a drag

Markets anticipate a rebound early in the shortened week following news of potential tariff removal on India. Despite oversold conditions, a...